ProPhase Labs, Inc.

Market Cap: Micro Cap
Industry: Pharmaceuticals & Biotechnology
ISIN: US74345W1080

USD

0.11

0 (0.09%)

May 18

NAS

View all stocks in this country

Score

Click here to find our call on this stock

Strong Sell

Sell

Hold

Buy

Strong Buy

Comparison

Company

Score

Quality

Valuation

Financial

Technical

Nature's Sunshine Products, Inc.

Chromadex Corp.

USANA Health Sciences, Inc.

ProPhase Labs, Inc.

LifeVantage Corp.

Natural Alternatives International, Inc.

Upexi, Inc.

Revolution Medicines, Inc.

Cidara Therapeutics, Inc.

MIRA Pharmaceuticals, Inc.

Bright Green Corp.

Why is ProPhase Labs, Inc. ?

Weak Long Term Fundamental Strength with a -252.99% CAGR growth in Operating Profits over the last 5 years

The company has been able to generate a Return on Equity (avg) of 9.38% signifying low profitability per unit of shareholders funds

Flat results in Dec 25

INTEREST(Q) At USD 4.26 MM has Grown at 174.89%

Risky -

The stock is trading risky as compared to its average historical valuations
Over the past year, while the stock has generated a return of -97.16%, its profits have risen by 19.3%

Falling Participation by Institutional Investors

Institutional investors have decreased their stake by -4.63% over the previous quarter and collectively hold 11.48% of the company
These investors have better capability and resources to analyse fundamentals of companies than most retail investors

Consistent Underperformance against the benchmark over the last 3 years

Along with generating -97.16% returns in the last 1 year, the stock has also underperformed S&P 500 in each of the last 3 annual periods

Real-Time Research Report

Verdict Report

How much should you sell?

All quantity irrespective of whether you are making profits or losses

(If sector exposure > 30%, please use optimiser tool to see which are the best stocks to hold in Pharmaceuticals & Biotechnology)

When to re-enter? - We will constantly monitor the company and review our call based on new data

Is ProPhase Labs, Inc. for you?

High Risk, Low Return

Absolute

Risk Adjusted

Volatility

ProPhase Labs, Inc.

-97.16%

-0.09

1142.21%

S&P 500

19.75%

1.50

13.19%

Quality

Management Risk

Growth

Capital Structure

Quality grade scale :

Below Average, Average, Good, Excellent

Quality key factors

Factor

Value

Sales Growth (5y)

-15.29%

EBIT Growth (5y)

-252.99%

EBIT to Interest (avg)

0.30

Debt to EBITDA (avg)

Net Debt to Equity (avg)

0.48

Sales to Capital Employed (avg)

0.59

Tax Ratio

23.71%

Dividend Payout Ratio

Pledged Shares

Institutional Holding

11.48%

ROCE (avg)

13.43%

ROE (avg)

9.38%

Valuation

Valuation Scorecard

Valuation grade scale :

Very Risky, Risky, Very Expensive, Expensive, Fair, Attractive, Very Attractive

Valuation Key Factors

Factor

Value

P/E Ratio

NA (Loss Making)

Industry P/E

Price to Book Value

0.20

EV to EBIT

-0.44

EV to EBITDA

-0.58

EV to Capital Employed

0.58

EV to Sales

1.54

PEG Ratio

Dividend Yield

ROCE (Latest)

-132.40%

ROE (Latest)

-292.87%

Technicals

Technical key factors

Indicator

Weekly

Monthly

MACD

Mildly Bullish

RSI

No Signal

Bollinger Bands

Sideways

Mildly Bearish

Moving Averages

Mildly Bearish (Daily)

KST

Mildly Bullish

Bearish

Dow Theory

Mildly Bullish

No Trend

OBV

Mildly Bearish

No Trend

Technical Indicator Scale: Bearish, Mildly Bearish, Sideways, Mildly Bullish, Bullish Turned

Technical Movement

Analyse All Technical Factors

Financial Trend

Financial Trend Scorecard

Financial Trend scale:

Very Negative, Negative, Flat, Positive, Very Positive, Outstanding

0What is working for the Company

NO KEY POSITIVE TRIGGERS

-2What is not working for the Company

INTEREST(Q)

At USD 4.26 MM has Grown at 174.89%

Here's what is not working for ProPhase Labs, Inc.

Interest

At USD 4.26 MM has Grown at 174.89%

period on period (QoQ)

MOJO Watch

Rising interest cost signifies increased borrowings

Interest Paid (USD MM)